✦ LIBER ✦

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy

✍ Scribed by Eugenio Maiorano; Meredith M. Regan; Giuseppe Viale; Mauro G. Mastropasqua; Marco Colleoni; Monica Castiglione-Gertsch; Karen N. Price; Richard D. Gelber; Aron Goldhirsch; Alan S. Coates

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 290 KB
Volume: 121
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0360-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ocular toxicity during adjuvant chemoend

Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer : Results from International Breast Cancer Study Group Trials

✍ Lorenzo Gianni; Ilaria Panzini; Sigui Li; Richard D. Gelber; John Collins; Stig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Anemia during adjuvant non-taxane chemot

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group

✍ Lorenzo Gianni; Bernard F. Cole; Ilaria Panzini; Raymond Snyder; Stig B. Holmber 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 165 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

Feasibility of two dose-dense FEC regime

Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG)

✍ Zsuzsanna Kahán; Stanislav Spanik; Maria Wagnerova; Tomas Skacel; Barbara Planko 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 208 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m